• Profile
Close

68Ga-labeled prostate-specific membrane antigen is a novel PET/CT tracer for imaging of hepatocellular carcinoma: A prospective pilot study

The Journal of Nuclear Medicine Feb 06, 2019

Kesler M, et al. - In this prospective pilot study, researchers evaluated the possible role of 68Ga-prostate-specific membrane antigen (PSMA) PET/CT in hepatocellular carcinoma (HCC) imaging. Study participants included 7 patients who had HCC with 41 liver lesions (37 suspected malignant lesions[tumor lesions] and 4 regenerative nodules). According to findings, 36 of the 37 tumor lesions and none of the regenerative nodules exhibited increased 68Ga-PSMA uptake, and only 10 lesions were 18F-FDG–avid. For imaging HCC patients, 68Ga- PSMA PET/CT was better than 18F-FDG PET/CT. Findings suggested that it is more common for HCC lesions to be hypervascular, taking up 68Ga-PSMA in tumoral microvessels. For imaging patients with HCC, 68Ga-PSMA PET/CT is a possible novel modality.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay